Imperial College London, legally the Imperial College of Science, Technology and Medicine, is a public research university in London. Imperial grew out of Prince Albert's vision for an area of culture, including the Royal Albert Hall, Victoria & Albert Museum, Natural History Museum, and several Royal Colleges.

During the past decade, Imperial College London conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 20 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 12 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imperial College London" #1 sponsor was "Imperial College London" with 79 trials, followed by "University College, London" with 3 trials sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imperial College London" #1 collaborator was "Imperial College London" with 16 trials as a collaborator, "Imperial College Healthcare NHS Trust" with 5 trials as a collaborator, "University College, London" with 5 trials as a collaborator, "Medical Research Council" with 4 trials as a collaborator and "University of Oxford" with 4 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 173 trials.

According to Clinical.Site data, the most researched conditions in "Imperial College London" are "Cardiovascular Diseases" (4 trials), "Chronic Obstructive Pulmonary Disease" (4 trials), "Stroke" (4 trials), "Coronary Heart Disease" (3 trials) and "HIV" (3 trials). Many other conditions were trialed in "Imperial College London" in a lesser frequency.

Most popular intervention types in "Imperial College London" are "Drug" (39 trials), "Other" (33 trials), "Device" (21 trials), "Biological" (10 trials) and "Diagnostic Test" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Rituximab" (3 trials), "Prednisolone" (2 trials), "Saline flushing" (2 trials) and "12 months of guideline-directed heart failure therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imperial College London" are 130 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Imperial College London". 6 are not yet recruiting, 31 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Imperial College London, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Imperial College London, 10 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 39 trials that are defined as “Not Applicable".

Imperial College London has several departments that took part in Clinical trials: "Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital" - 10 trials, "Centre for Neuropsychopharmacology; Division of Brain Sciences; Imperial College London; Burlington Danes Building; Hammersmith Hospital campus; 160 Du Cane Road" - 2 trials, "Kennedy Institute Clinical Trials Unit, 4 West, Charing Cross Hospital" - 2 trials, "Imperial Clinical Trials Unit" - 2 trials, "Department of Surgery and Cancer, St Mary's Campus, Praed Street, Imperial College London" - 2 trials